Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician. - Wikidata - awgldk - TriplyDB

Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.

Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.

http://www.wikidata.org/entity/Q37692028

about

Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics Reversing the myths obstructing the determination of optimal age- and disease-based drug dosing in pediatrics Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients Are vancomycin trough concentrations adequate for optimal dosing?Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.Pharmacokinetic modeling of therapies for systemic lupus erythematosus.Opportunities for model-based precision dosing in the treatment of sickle cell anemia.Personalised dosing of medicines for children.Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies.Scalpels not hammers: The way forward for precision drug prescription.In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.Dosage Adjustments Related to Young or Old Age and Organ Impairment.Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

P2860

Q26853629-72B56204-F64F-482D-9149-856C42B668F2 Q35104991-1635AFDD-FA1B-402D-8984-D09B81A964EF Q36089634-501897E4-6A50-4827-9877-364A10839FBC Q36327652-108352F6-FDED-4972-8D1F-7B11A660D2D2 Q36667084-888E9E03-C132-489D-9103-AC5FE1FEB5CE Q36777485-C1D1B710-9829-4826-853A-27DEEC921D1B Q37224427-C9628AA6-6088-4706-BE63-2B7BCAD8F1BC Q37544400-3E6E42EF-AF1C-41B6-9A6E-8DD1727B07B3 Q37835819-88CD2571-55CD-414A-86B4-DFB14BC1DC81 Q38527434-47EBA2CF-F7F9-492F-8BFE-022B46A7DD42 Q38542910-690E8ED6-02C7-45E5-83DC-6161CC3F0B07 Q38642609-33762677-E3AD-4F94-BD81-3B06EFFFEBE7 Q38749764-89CD5E3B-FD09-4A0F-9564-AE57222E37A1 Q38759413-B3926489-DE62-4D99-B82E-EA95BECAEA0D Q38958282-805E4E77-0FF3-480D-8D16-B40212C020B7 Q39041485-DE2C25CB-5667-4427-89CC-E4A5CAAD19FC Q41901707-B0558309-BCDF-4589-81DB-880E65119BA6 Q45254867-FF34B891-FE81-4D87-96F0-F2D6CE4047E1 Q46066680-ACEA44A4-6806-4794-8466-9607B049721E Q49171317-A8628CFD-4E46-4B3A-B65B-BBBA63FAA1CD

P2860

Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.

http://www.wikidata.org/entity/Q37692028

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Practical, individualized dosi ...... he clinical pharmacometrician.

@en

Practical, individualized dosi ...... he clinical pharmacometrician.

@nl

type

label

Practical, individualized dosi ...... he clinical pharmacometrician.

@en

Practical, individualized dosi ...... he clinical pharmacometrician.

@nl

prefLabel

Practical, individualized dosi ...... he clinical pharmacometrician.

@en

Practical, individualized dosi ...... he clinical pharmacometrician.

@nl

P1433

Q37692028-2A363768-3A8D-44C4-AE18-841286D80AFF

P1476

Q37692028-B25BA4DE-5279-49C3-B7DF-0507F9224C2F

P2093

Q37692028-5DBC7E35-EAB7-4010-B96E-F2DA82478083

Q37692028-E2D4F0AF-4ED4-4CD7-A9A8-257E5E3BD292

P2860

Q37692028-07AC51C3-BDB8-4810-B714-E32668CC896A

Q37692028-29510E35-682B-48BD-AF2A-8532AD9C623C

Q37692028-2DBB7F78-C0E7-4ACE-8795-0C0BC6EF4B46

Q37692028-32E52A34-D826-4158-A4F9-61024A6CA028

Q37692028-3B6C287F-3187-4393-B608-2829CABFCD3F

Q37692028-4392517F-07D3-4877-8409-DD479C7A43EA

Q37692028-5CD98051-6116-4579-A138-0BD5BD5E7C32

Q37692028-634A1BE6-2C27-4CD9-89C5-0C8F93244193

Q37692028-6EBEB23D-DFCC-4689-833B-913A0D624912

Q37692028-7B590A92-D332-4D07-B535-C969DA0DC147

P304

Q37692028-695CD19B-8CBB-45E5-B63C-86F10F53E16D

P31

Q37692028-8D029648-B661-40AE-838F-6676422E378A

P356

Q37692028-D467624A-8ACC-4CA8-9C15-966B97760472

P433

Q37692028-32A877EF-6576-4070-8DA6-796ED18BD13B

P478

Q37692028-74AB7B89-E923-456F-8058-CC53E52AADDC

P577

Q37692028-0D7F4351-65DF-4173-B896-9EF225BF4FB6

P698

Q37692028-D96B3D5B-8C14-486F-A1D2-AEF5EF2C985C

P356

0091270009356572

P1433

The Journal of Clinical Pharmacology

P1476

Practical, individualized dosi ...... he clinical pharmacometrician.

@en

P2093

Michael Neely

http://www.w3.org/2001/XMLSchema#string

Roger Jelliffe

http://www.w3.org/2001/XMLSchema#string

P2860

Bayesian design using adult data to augment pediatric trials.

Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates.

Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy.

Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings.

Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.

Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimization

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

An updated comparison of drug dosing methods. Part IV: Vancomycin.

P304

842-847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270009356572

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20154293

http://www.w3.org/2001/XMLSchema#string